• Join
  • Login
  • Contact

Search abstracts / presentations

Biosimilars and Biobetters: Interchangeability Issues for Pharmacists, Physicians and Regulators

  • In: Biological drugs and gene therapy - Hot topics on regulation and policies affecting use on Tuesday, 4 September 2018, 9:00-12:00
  • At: Glasgow (Scotland) (2018)
  • Type: Presentation
  • By: RAMZAN, Iqbal (The University of Sydney, Australia)
  • Abstract:

    Biologics (and their interchangeable equivalents, biosimilars) and their more efficacious, successors, biobetters) are taking up a larger share of the therapeutics drug market compared to small molecule drugs. They are potent, more expensive, and complex in their therapeutic utility. Pharmacists are the primary health professionals who will


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses